Article Text

PDF
Gonadotropin releasing hormone analogues for endometriosis

Abstract

Gonadotropin releasing hormone (GnRH) analogues are now marketed in the UK for the treatment of patients with endometriosis. Endometriosis is an oestrogen-dependent disorder, and conventional medical treatments have relied on mechanisms that oppose the effects of oestrogen, e.g. an androgen (danazol) or a progestagen (norethisterone). GnRH analogues work by suppressing oestrogen secretion.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.